NCT00287521 A Study of Glaucoma Therapy to Treat Open-Angle Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE2
NCT00283764 Safety And Efficacy Of Xalatan Delivered Using Either A Conventional Dropper Bottle or A Delivery Device Status WITHDRAWN Phase PHASE3
NCT00277498 A 12-week, Randomized, Double-masked, Parallel Group Comparison of Evening Dosing With Xalacom in Subjects With Glaucoma Status COMPLETED Phase PHASE3
NCT00230763 Determination Of Predictive Factors Allowing To An Additional 10% Reduction Of Intra-Ocular Pressure Status COMPLETED Phase PHASE3
NCT00219596 Xalacom And Combination Of Unfixed Latanoprost And Timolol In Subjects With Open-Angle Glaucoma Or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT00168363 Safety and Efficacy of Brimonidine in Patients With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT00159653 A 12-Week, Randomized, Double-Masked, Parallel Group Comparison Of Evening Dosing With Xalacom In Subjects With Glaucoma Status COMPLETED Phase PHASE3
NCT00150267 A 5-Year Postmarketing Safety Study Of Xalcom In Patients With Open Angle Glaucoma Or Ocular Hypertension Status COMPLETED Phase PHASE3
NCT00143429 Corneal Versus Conjunctival Delivery Using a Delivery Device Status WITHDRAWN Phase PHASE2
NCT00143208 Evaluation Of Intraocular Pressure Lowering-Effect Of Xalacom In Patients With Poag Or Oh. Status COMPLETED Phase PHASE4
NCT00140062 Efficacy And Safety Of Xalatan Compared To Usual Care In Patients With Open Angle Glaucoma Or Ocular Hypertension. Status COMPLETED Phase PHASE4
NCT00140049 A 12week, Randomized, Evaluator-Masked, Parallel Group Comparing Evening Dosing Of Xalacom Vs Cosopt In Subj W/ Glaucoma Status COMPLETED Phase PHASE4
NCT00121147 Additivity Study: Additive Effect on Eye Pressure of Azopt and Alphagan P to Travatan Status COMPLETED Phase NA
NCT00108017 Comparison of the Effects of Two Glaucoma Drugs Over 24 Hours (0507A-137)(COMPLETED) Status COMPLETED Phase PHASE3
NCT00069719 Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-Angle Glaucoma or Ocular Hypertension Patients Status COMPLETED Phase PHASE2
NCT00069706 Phase II Safety and Efficacy Study to Evaluate a Glaucoma Therapy in Open-angle Glaucoma or Ocular Hypertension Patients Status COMPLETED Phase PHASE2
NCT00061542 Safety and Efficacy Study of BETOPTIC S 0.25% and Timolol Gel-forming Solution 0.25% and 0.5% in Pediatric Patients With Glaucoma or Ocular Hypertension Status COMPLETED Phase PHASE3